| Bioactivity | Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab can be used to research chronic obstructive pulmonary disease[1]. |
| Name | Tozorakimab |
| CAS | 2376858-66-9 |
| Formula | CH3 |
| Molar Mass | 15.03 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. F. Reid, et al. Safety, Pharmacokinetics and Immunogenicity of the Anti-Interleukin-33 Antibody, Tozorakimab: Results of a Phase 1 Study in Healthy Adults and Patients with Chronic Obstructive Pulmonary Disease. |